David A. Ramies — AbbVie (United States)

Area of research

Pulmonary and Respiratory Medicine · Oncology

Research interest

Research interests include Medicine, Cabozantinib, Pharmacokinetics, Hepatocellular carcinoma, Sorafenib, and Clinical endpoint.

Recent publications

Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton‐Pump Inhibitors

Clinical Pharmacology in Drug Development 2022cited by 26position: middledoi

Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Cabozantinib

The Journal of Clinical Pharmacology 2016cited by 55position: middledoi

Activity of cabozantinib (XL184) in hepatocellular carcinoma: Results from a phase II randomized discontinuation trial (RDT).

Journal of Clinical Oncology 2012cited by 109position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2016–2016)— · 1 papers (2022–2022)— · 1 papers (2016–2016)— · 1 papers (2022–2022)Veerendra Munugalavadla · AstraZeneca (United States)1 papers (2022–2022)— · 1 papers (2022–2022)Haran Burri · University Hospital of Geneva1 papers (2022–2022)— · 1 papers (2022–2022)— · 1 papers (2022–2022)— · 1 papers (2016–2016)John C. Byrd · Comprehensive Blood & Cancer Center1 papers (2022–2022)— · 1 papers (2012–2012)Richard Alfred Preston · University of Miami1 papers (2016–2016)Xiaodong Shen · Nanjing Tech University1 papers (2012–2012)— · 1 papers (2022–2022)Eric Van Cutsem · KU Leuven1 papers (2012–2012)Lianqing Zheng · Florida State University1 papers (2022–2022)Tsai‐Shen Yang · Zhejiang Chinese Medical University1 papers (2012–2012)Linh T. Nguyen · Medical College of Wisconsin1 papers (2016–2016)— · 1 papers (2022–2022)

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Pulmonary and Respiratory Medicine · Oncology →